4-cymene has been researched along with Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Fuster, MG; García, G; Montalbán, MG; Moulefera, I; Pérez, J; Víllora, G | 1 |
| Almeida, JRGS; Baj, T; Batista, MVA; Coutinho, HDM; de Oliveira, MA; Duarte, MC; Guimarães, AG; Kowalska, G; Kowalski, R; Pina, LTS; Quintans, JSS; Quintans-Júnior, LJ; Santos, LABO; Santos, WBR; Serafini, MR; Trindade, GGG | 1 |
| Dharmasivam, M; Dorairaj, DP; Echeverria, C; Haribabu, J; Karvembu, R; Malekshah, RE; Mohamed Subarkhan, MK | 1 |
| Amarowicz, R; Hassan, SMH; Hossain, R; Islam, MT; Martins, N; Ray, P; Salehi, B; Sharifi-Rad, J | 1 |
| Chi, KW; Jeong, YJ; Jo, JH; Kang, SC; Lah, MS; Mishra, A | 1 |
| Clavel, CM; Dyson, PJ; Griffioen, AW; Nowak-Sliwinska, P; Păunescu, E; Scopelliti, R | 1 |
| Arcangeli, A; Contel, M; Fernández-Gallardo, J; Guerri, A; Massai, L; Messori, L; Pillozzi, S | 1 |
| Balacescu, L; Balacescu, O; Berindan-Neagoe, I; Cheminel, T; Grozav, A; Therrien, B | 1 |
| Gobec, S; Kljun, J; Kos, J; Mitrović, A; Sosič, I; Turel, I | 1 |
1 review(s) available for 4-cymene and Neoplasms
| Article | Year |
|---|---|
p-Cymene metallo-derivatives: An overview on anticancer activity.
Topics: Animals; Antineoplastic Agents; Cymenes; Humans; Metals; Neoplasms | 2020 |
8 other study(ies) available for 4-cymene and Neoplasms
| Article | Year |
|---|---|
Synthesis and Characterization of New Ruthenium (II) Complexes of Stoichiometry [Ru(
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; HeLa Cells; Humans; Neoplasms; Ruthenium | 2022 |
Antinociceptive Effect of a p-Cymene/β-Cyclodextrin Inclusion Complex in a Murine Cancer Pain Model: Characterization Aided through a Docking Study.
Topics: Analgesics; Animals; beta-Cyclodextrins; Cancer Pain; Cyclodextrins; Humans; Mice; Molecular Docking Simulation; Neoplasms; Pain; Solubility | 2023 |
Ru(II)-
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Cymenes; Ligands; Mice; Neoplasms; Ruthenium | 2023 |
Anticancer potency studies of coordination driven self-assembled arene–Ru-based metalla-bowls.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cymenes; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Molecular Conformation; Monoterpenes; Neoplasms; Organometallic Compounds; Pyridines; Ruthenium | 2014 |
Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Coordination Complexes; Crystallography, X-Ray; Cymenes; Humans; Models, Molecular; Monoterpenes; Neoplasms; Ruthenium | 2015 |
Design, synthesis and characterisation of new chimeric ruthenium(II)-gold(I) complexes as improved cytotoxic agents.
Topics: Antineoplastic Agents; Cathepsin B; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Cymenes; DNA; Gold; Humans; Models, Molecular; Monoterpenes; Neoplasms; Ruthenium | 2015 |
Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cymenes; Female; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Monoterpenes; Neoplasms; Ovarian Neoplasms; Ruthenium; Thiazoles; Transcriptome | 2015 |
Clioquinol-ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity.
Topics: Antineoplastic Agents; Cathepsin B; Cell Line, Tumor; Clioquinol; Cymenes; Enzyme Inhibitors; Humans; Monoterpenes; Neoplasm Invasiveness; Neoplasms; Organometallic Compounds; Ruthenium | 2016 |